What Happened to Oklo Inc. (OKLO)?

Oklo Inc., founded in 2013 by Jacob and Caroline DeWitte, emerged with a vision to revolutionize energy production through advanced nuclear reactors. The company's name is inspired by the natural nuclear fission reactor discovered in Oklo, Gabon, emphasizing its focus on inherently safe, self-sustaining nuclear technology. Oklo's primary product line is the Aurora powerhouse, a fast-fission reactor designed to generate 15-75 MWe of electrical power, capable of running on recycled nuclear fuel.

Initially operating as UPower, Oklo participated in the Y Combinator startup accelerator in 2014 and saw OpenAI co-founder Sam Altman become Chairman of its Board of Directors in 2015. A significant turning point occurred in May 2024 when Oklo merged with AltC Acquisition Corp., a SPAC led by Sam Altman, and began trading publicly on the NYSE under the ticker 'OKLO,' raising approximately $306 million in gross proceeds. Altman later stepped down as Chairman in April 2025 to avoid conflicts of interest ahead of potential energy supply agreements between OpenAI and Oklo.

Oklo has navigated a complex regulatory landscape. While its initial combined license application (COLA) for a 1.5 MW Aurora powerhouse was denied by the U.S. Nuclear Regulatory Commission (NRC) in 2022 due to insufficient information, this pioneering effort laid crucial groundwork for advanced reactor licensing. In May 2025, Oklo was selected for the U.S. Department of Energy's (DOE) Reactor Pilot Program, a federal initiative aimed at fast-tracking advanced nuclear deployment, particularly for AI data centers.

The company's strategic expansion includes the acquisition of radioisotopes company Atomic Alchemy in March 2025, aiming to produce radioisotopes for medical and industrial applications through its nuclear fuel recycling process and fast reactor technology. As of March 2026, Oklo achieved several critical regulatory milestones. Its subsidiary, Atomic Alchemy, received its first materials license from the NRC, allowing it to handle, process, and distribute isotopes from its Idaho Radiochemistry Laboratory, with initial commercial sales expected in 2026. Concurrently, the DOE approved the Nuclear Safety Design Agreements (NSDA) for Oklo's Aurora powerhouse project at Idaho National Laboratory (INL) and for Atomic Alchemy's Groves Isotopes Test Reactor in Texas, accelerating both power generation and isotope production plans.

Financially, Oklo remains a pre-revenue company, reporting a net loss of $105.7 million for 2025. However, it boasts a strong liquidity position, ending 2025 with approximately $1.4 billion in cash and marketable securities, further bolstered by an additional $1.182 billion raised in January 2026, bringing its pro forma liquidity to around $2.582 billion. This capital is crucial for funding its ambitious construction and development plans, including the Aurora-INL project targeting commercial operations by 2028. A significant commercial development in January 2026 was a partnership with Meta, which agreed to support a 1.2 GW nuclear power campus in Ohio, providing essential funding and highlighting the growing demand for reliable, carbon-free energy for AI infrastructure. Oklo's stock has experienced significant volatility, surging in 2025 and early 2026 due to these partnerships and regulatory progress, though it has also seen declines. The company's focus has now shifted from planning to execution, with investors closely watching its ability to deliver on its projects and generate revenue, which is not expected until late 2027 or early 2028 for power generation.